Zimmer Biomet Holdings Inc (ZBH)
121.66
+3.20
(+2.70%)
USD |
NYSE |
May 03, 16:00
121.65
-0.01
(-0.01%)
Pre-Market: 20:00
Zimmer Biomet Holdings Cash from Financing (TTM): -606.90M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -606.90M |
| December 31, 2023 | -763.50M |
| September 30, 2023 | -825.50M |
| June 30, 2023 | -823.40M |
| March 31, 2023 | -860.00M |
| December 31, 2022 | -843.80M |
| September 30, 2022 | -1.186B |
| June 30, 2022 | -1.418B |
| March 31, 2022 | -1.301B |
| December 31, 2021 | -1.306B |
| September 30, 2021 | -936.50M |
| June 30, 2021 | -553.00M |
| March 31, 2021 | -2.110B |
| December 31, 2020 | -421.80M |
| September 30, 2020 | -318.20M |
| June 30, 2020 | -574.00M |
| March 31, 2020 | 848.10M |
| December 31, 2019 | -779.90M |
| September 30, 2019 | -872.70M |
| June 30, 2019 | -872.00M |
| March 31, 2019 | -2.279B |
| December 31, 2018 | -1.302B |
| September 30, 2018 | -1.260B |
| June 30, 2018 | -1.283B |
| March 31, 2018 | -624.80M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.210B |
| September 30, 2017 | -1.287B |
| June 30, 2017 | -446.80M |
| March 31, 2017 | 345.80M |
| December 31, 2016 | -743.20M |
| September 30, 2016 | -972.50M |
| June 30, 2016 | -1.636B |
| March 31, 2016 | -1.295B |
| December 31, 2015 | 7.107B |
| September 30, 2015 | 7.382B |
| June 30, 2015 | 7.510B |
| March 31, 2015 | 7.289B |
| December 31, 2014 | -570.10M |
| September 30, 2014 | -429.20M |
| June 30, 2014 | -353.00M |
| March 31, 2014 | -305.50M |
| December 31, 2013 | -467.30M |
| September 30, 2013 | -403.20M |
| June 30, 2013 | -579.80M |
| March 31, 2013 | -759.90M |
| December 31, 2012 | -436.50M |
| September 30, 2012 | -340.90M |
| June 30, 2012 | -393.60M |
| March 31, 2012 | -368.40M |
| December 31, 2011 | -455.80M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-2.110B
Minimum
Mar 2021
848.10M
Maximum
Mar 2020
-826.24M
Average
-834.65M
Median
Cash from Financing (TTM) Benchmarks
| Stryker Corp | -1.531B |
| Align Technology Inc | -351.10M |
| Edwards Lifesciences Corp | -442.70M |
| ResMed Inc | -914.60M |
| Globus Medical Inc | -231.82M |